Skip to main content

Surveillance Colonoscopy Rarely IDs Cancer in Older Adults

Medically reviewed by Carmen Pope, BPharm. Last updated on April 4, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, April 4, 2024 -- Colorectal cancer (CRC) is rarely detected from surveillance colonoscopy among older adults, regardless of prior adenoma findings, according to a study published online April 2 in JAMA Network Open.

Jeffrey K. Lee, M.D., M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues estimated surveillance colonoscopy yields in older adults. The analysis included 9,601 individuals 70 to 85 years who received 9,740 surveillance colonoscopies at a large, community-based U.S. health care system (2017 through 2019) and had an adenoma detected ≥12 months previously.

The researchers reported that CRC yields were found in 0.3 percent of procedures, advanced adenoma in 11.7 percent, and advanced neoplasia in 12.0 percent. There were no significant differences in yields across age groups. CRC yields were significantly higher for colonoscopies among patients with a prior advanced adenoma versus nonadvanced adenoma (0.5 versus 0.2 percent). A similar pattern was seen for advanced neoplasia (16.5 versus 10.6 percent). Detection of advanced neoplasia at surveillance was associated with prior advanced adenoma (adjusted odds ratio [aOR], 1.65), body mass index ≥30 versus <25 kg/m2 (aOR, 1.21), and having ever smoked tobacco (aOR, 1.14). There was an inverse association between Asian or Pacific Islander race and advanced neoplasia.

"With current guidelines offering no specific age at which to stop surveillance colonoscopy, the study findings can inform clinicians and older patients regarding the potential benefits (or lack of benefits) of continuing with postpolypectomy surveillance in the context of the life expectancy of the patient and weighed against the rare but known harms of colonoscopy," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...

Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...

American College of Surgeons, Oct. 19-22

The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.